Importance of UDP-glucuronosyltransferase 1A1*6 for irinotecan toxicities in Japanese cancer patients

被引：40
|
作者：
Sai, Kimie [1 ]
Saito, Yoshiro [2 ]
Sakamoto, Hiromi [3 ]
Shirao, Kuniaki [4 ]
Kurose, Koichi [5 ]
Saeki, Mayumi [6 ]
Ozawa, Shogo [7 ]
Kaniwa, Nahoko [5 ]
Hirohashi, Setsuo [8 ]
Saijo, Nagahiro [9 ]
Sawada, Jun-ichi [2 ]
Yoshida, Teruhiko [3 ]
机构：
[1] Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, Tokyo 1588501, Japan
[2] Natl Inst Hlth Sci, Dept Biochem & Immunochem, Setagaya Ku, Tokyo 1588501, Japan
[3] Natl Inst Canc Res, Div Genet, Chuo Ku, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Div Internal Med, Chuo Ku, Tokyo 1040045, Japan
[5] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo 1588501, Japan
[6] Natl Inst Hlth Sci, Project Team Pharmacogenet, Setagaya Ku, Tokyo 1588501, Japan
[7] Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan
[8] Natl Inst Canc Res, Div Pathol, Chuo Ku, Tokyo 1040045, Japan
[9] Natl Canc Ctr Hosp E, Chiba 2778577, Japan
来源：
CANCER LETTERS | 2008年 / 261卷 / 02期
关键词：
UGT1A1; pharmacogenetics; irinotecan; SN-38;
D O I：
10.1016/j.canlet.2007.11.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent pharmacogenetic studies on irinotecan have revealed the impact of UDP glucuronosyltransferase (UGT) 1A1*28 on severe irinotecan toxicities. Although the clinical role of UGT1A1*6, which is specifically detected in East Asian patients, in irinotecan toxicities is suggested, clear evidence remains limited. To examine the impact of *6, the association of UGT1A1 genotypes with severe irinotecan toxicities was retrospectively investigated in Japanese cancer patients. A significant *6-dependent increase in the incidence of grade 3 or 4 neutropenia was observed in 49 patients on irinotecan mono-therapy (p = 0.012). This study further clarifies the clinical importance of *6 in irinotecan therapy in East Asians. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：165 / 171
页数：7
相关论文
共 50 条
  • [31] Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers
    Smith, CM
    Faucette, SR
    Wang, HB
    LeCluyse, EL
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2005, 19 (02) : 96 - 108
  • [32] Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups
    Innocenti, F
    Grimsley, C
    Das, S
    Ramírez, J
    Cheng, C
    Kuttab-Boulos, H
    Ratain, MJ
    Di Rienzo, A
    PHARMACOGENETICS, 2002, 12 (09): : 725 - 733
  • [33] High throughput screening assay for UDP-glucuronosyltransferase 1A1 glucuronidation profiling
    Trubetskoy, O. V.
    Finel, M.
    Kurkela, M.
    Fitzgerald, M.
    Peters, N. R.
    Hoffman, F. M.
    Trubetskoy, V. S.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (03) : 343 - 354
  • [34] Variations in the UDP-glucuronosyltransferase 1A1 gene for the development of unconjugated hyperbilirubinemia in Taiwanese
    Huang, Yang-Yang
    Huang, May-Jen
    Yang, Sieng-Sien
    Teng, Hsiu-Chen
    Huang, Ching-Shan
    PHARMACOGENOMICS, 2008, 9 (09) : 1229 - 1235
  • [35] Edaravone Affects the Activity of Bone Cancer Treatment Relevant Enzyme UDP-Glucuronosyltransferase (UGT) 1A1
    Dong, Zhen-Ling
    Ma, Hou-Hai
    Ma, Hou-Sheng
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (09): : 1839 - 1842
  • [36] Histone Modifications Regulate the Developmental Expression of Human Hepatic UDP-Glucuronosyltransferase 1A1
    Nie, Ya-Li
    Meng, Xiang-Guang
    Liu, Jing-Yang
    Yan, Liang
    Wang, Pei
    Bi, Hong-Zheng
    Kan, Quan-Cheng
    Zhang, Li-Rong
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (12) : 1372 - 1378
  • [37] Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1
    Watanabe, Y
    Nakajima, M
    Ohashi, N
    Kume, T
    Yokoi, T
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 589 - 595
  • [38] Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties
    Ohno, Shuji
    Kawana, Kiyoshi
    Nakajin, Shizuo
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (04) : 688 - 694
  • [39] Function, Genetic Polymorphism, and Transcriptional Regulation of Human UDP-glucuronosyltransferase (UGT) 1A1
    Sugatani, Junko
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (02) : 83 - 92
  • [40] Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination
    Jeong, H.
    Choi, S.
    Song, J. W.
    Chen, H.
    Fischer, J. H.
    XENOBIOTICA, 2008, 38 (01) : 62 - 75
12345